As of 2026-06-01, the Relative Valuation of AxoGen Inc (AXGN) is (17.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.48 USD, the upside of AxoGen Inc based on Relative Valuation is -144.6%.
The range of the Relative Valuation is (19.27) - (17.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.8x - 35.0x | 34.8x |
| Forward P/E multiples | 19.7x - 28.5x | 23.2x |
| Fair Price | (19.27) - (17.28) | (17.59) |
| Upside | -148.8% - -143.8% | -144.6% |
| Date | P/E |
| 2026-05-29 | -65.15 |
| 2026-05-28 | -66.70 |
| 2026-05-27 | -65.79 |
| 2026-05-26 | -68.40 |
| 2026-05-22 | -67.49 |
| 2026-05-21 | -68.16 |
| 2026-05-20 | -70.44 |
| 2026-05-19 | -70.44 |
| 2026-05-18 | -69.22 |
| 2026-05-15 | -67.64 |
| 2026-05-14 | -67.57 |
| 2026-05-13 | -66.48 |
| 2026-05-12 | -67.54 |
| 2026-05-11 | -67.31 |
| 2026-05-08 | -69.40 |
| 2026-05-07 | -71.63 |
| 2026-05-06 | -71.75 |
| 2026-05-05 | -72.17 |
| 2026-05-04 | -70.34 |
| 2026-05-01 | -71.42 |
| 2026-04-30 | -71.28 |
| 2026-04-29 | -68.92 |
| 2026-04-28 | -69.29 |
| 2026-04-27 | -65.00 |
| 2026-04-24 | -64.77 |
| 2026-04-23 | -61.73 |
| 2026-04-22 | -61.05 |
| 2026-04-21 | -59.22 |
| 2026-04-20 | -61.43 |
| 2026-04-17 | -63.53 |
| 2026-04-16 | -61.66 |
| 2026-04-15 | -57.36 |
| 2026-04-14 | -56.86 |
| 2026-04-13 | -55.23 |
| 2026-04-10 | -52.74 |
| 2026-04-09 | -54.49 |
| 2026-04-08 | -56.10 |
| 2026-04-07 | -51.14 |
| 2026-04-06 | -53.86 |
| 2026-04-02 | -56.83 |
| 2026-04-01 | -55.41 |
| 2026-03-31 | -54.67 |
| 2026-03-30 | -51.68 |
| 2026-03-27 | -51.61 |
| 2026-03-26 | -53.22 |
| 2026-03-25 | -54.91 |
| 2026-03-24 | -53.81 |
| 2026-03-23 | -52.39 |
| 2026-03-20 | -50.79 |
| 2026-03-19 | -51.42 |